White Paper: Designing Auto-Injectors for Multiple Drug Viscosities
Components — specifically springs used for device activation and needle retraction — play a key role in creating a flexible design. Pharma and biopharma OEMS need to engage spring suppliers at the very onset of new device planning.
Given the range of physical properties of drugs and biologics being administered via auto-injectors, it is crucial for pharma and biopharma industry OEMs to optimize device designs to be as adaptable, and thereby as cost-effective, as possible.
The inclusion of the metal spring component manufacturer, along with the NPD and CM, in the initial design phase of injectable drug delivery systems — particularly auto-injectors, with their massive growth forecast — represents a huge potential savings in time and money to pharmaceutical and biopharmaceutical industry OEMs.